The Bioelectronics and Biosensors market encompasses integrated electronic devices that detect, monitor, or modulate biological signals, spanning implantable bioelectronic systems, wearable biosensors, and point‑of‑care diagnostic platforms. Its relevance is anchored in the convergence of healthcare, IoT, and personalized medicine, driving faster, data‑rich clinical decision‑making. According to recent industry reports, the Bioelectronics and Biosensors market size reached approximately $36 billion in 2025, and the market forecast projects it to climb to $55 billion by 2033, delivering a CAGR of roughly 6.5% over the forecast period. The growth outlook is propelled by expanding chronic disease prevalence, rising demand for remote patient monitoring, and substantial R&D investment in nanomaterials and flexible electronics. Macro drivers such as supportive regulatory pathways for digital health, escalating healthcare expenditures, and the rollout of 5G networks further accelerate industry expansion.